122 related articles for article (PubMed ID: 38428023)
21. Modulatory effect of caffeic acid on cholinesterases inhibitory properties of donepezil.
Agunloye OM; Oboh G
J Complement Integr Med; 2017 Sep; 15(1):. PubMed ID: 28941354
[TBL] [Abstract][Full Text] [Related]
22. Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
Eskander MF; Nagykery NG; Leung EY; Khelghati B; Geula C
Brain Res; 2005 Oct; 1060(1-2):144-52. PubMed ID: 16212945
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of cholinesterase inhibition by inorganic mercury.
Frasco MF; Colletier JP; Weik M; Carvalho F; Guilhermino L; Stojan J; Fournier D
FEBS J; 2007 Apr; 274(7):1849-61. PubMed ID: 17355286
[TBL] [Abstract][Full Text] [Related]
24. Cholinesterase inhibitory activity of chlorophenoxy derivatives-Histamine H3 receptor ligands.
Łażewska D; Jończyk J; Bajda M; Szałaj N; Więckowska A; Panek D; Moore C; Kuder K; Malawska B; Kieć-Kononowicz K
Bioorg Med Chem Lett; 2016 Aug; 26(16):4140-5. PubMed ID: 27445168
[TBL] [Abstract][Full Text] [Related]
25. New data on the structure of the acyl pocket in cholinesterases.
Moralev SN
Dokl Biochem; 2000; 375():215-7. PubMed ID: 11296473
[No Abstract] [Full Text] [Related]
26. Probing the mid-gorge of cholinesterases with spacer-modified bivalent quinazolinimines leads to highly potent and selective butyrylcholinesterase inhibitors.
Chen X; Tikhonova IG; Decker M
Bioorg Med Chem; 2011 Feb; 19(3):1222-35. PubMed ID: 21232964
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of acetyl- and butyrylcholinesterase and amylase release from canine pancreas.
Oguchi Y; Dressel TD; Borner JW; Miller J; Goodale RL
Pancreas; 1989; 4(4):423-8. PubMed ID: 2474812
[TBL] [Abstract][Full Text] [Related]
28. Cholinesterases exhibiting aryl acylamidase activity in human amniotic fluid.
Jayanthi LD; Balasubramanian N; Balasubramanian AS
Clin Chim Acta; 1992 Feb; 205(3):157-66. PubMed ID: 1349516
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Acetylcholinesterase and Butyrylcholinesterase by a Plant Secondary Metabolite Boldine.
Kostelnik A; Pohanka M
Biomed Res Int; 2018; 2018():9634349. PubMed ID: 29850593
[TBL] [Abstract][Full Text] [Related]
30. Ursolic and oleanolic acid derivatives with cholinesterase inhibiting potential.
Loesche A; Köwitsch A; Lucas SD; Al-Halabi Z; Sippl W; Al-Harrasi A; Csuk R
Bioorg Chem; 2019 Apr; 85():23-32. PubMed ID: 30599410
[TBL] [Abstract][Full Text] [Related]
31. Novel tetrahydroacridine derivatives with iodobenzoic acid moiety as multifunctional acetylcholinesterase inhibitors.
Skibiński R; Czarnecka K; Girek M; Bilichowski I; Chufarova N; Mikiciuk-Olasik E; Szymański P
Chem Biol Drug Des; 2018 Feb; 91(2):505-518. PubMed ID: 28944565
[TBL] [Abstract][Full Text] [Related]
32. Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase.
Darvesh S; Darvesh KV; McDonald RS; Mataija D; Walsh R; Mothana S; Lockridge O; Martin E
J Med Chem; 2008 Jul; 51(14):4200-12. PubMed ID: 18570368
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
[TBL] [Abstract][Full Text] [Related]
34. Diagnoses of Pathological States Based on Acetylcholinesterase and Butyrylcholinesterase.
Pohanka M
Curr Med Chem; 2020; 27(18):2994-3011. PubMed ID: 30706778
[TBL] [Abstract][Full Text] [Related]
35. The mechanism and benefit of human butyrylcholinesterase activation by what would otherwise be inhibitors.
Stojan J
Chem Biol Interact; 2019 Aug; 308():350-356. PubMed ID: 31173753
[TBL] [Abstract][Full Text] [Related]
36. Biochemical differentiation of cholinesterases from normal and Alzheimer's disease cortex.
Ciro A; Park J; Burkhard G; Yan N; Geula C
Curr Alzheimer Res; 2012 Jan; 9(1):138-43. PubMed ID: 21244353
[TBL] [Abstract][Full Text] [Related]
37. [Cholinesterases: structure, role, and inhibition].
Bosak A; Katalinić M; Kovarik Z
Arh Hig Rada Toksikol; 2011 Jun; 62(2):175-90. PubMed ID: 21705306
[TBL] [Abstract][Full Text] [Related]
38. Biochemical evaluation of photolabile precursors of choline and of carbamylcholine for potential time-resolved crystallographic studies on cholinesterases.
Peng L; Silman I; Sussman J; Goeldner M
Biochemistry; 1996 Aug; 35(33):10854-61. PubMed ID: 8718877
[TBL] [Abstract][Full Text] [Related]
39. The ratio of acetylcholinesterase to butyrylcholinesterase influences the specificity of assays for each enzyme in human brain.
Huff FJ; Reiter CT; Rand JB
J Neural Transm; 1989; 75(2):129-34. PubMed ID: 2918305
[TBL] [Abstract][Full Text] [Related]
40. In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase.
Kandasamy S; Loganathan C; Sakayanathan P; Karthikeyan S; Stephen AD; Marimuthu DK; Ravichandran S; Sivalingam V; Thayumanavan P
Int J Biol Macromol; 2021 Aug; 185():750-760. PubMed ID: 34216669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
